Tirzepatide (Mounjaro)

Tirzepatide (Mounjaro)

Treatment as low as $800 per month. Call today to learn more.

​​​​​​​Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, representing a new class of medicines studied for the treatment of obesity. Tirzepatide is a single peptide that triggers the body's receptors for GIP and GLP-1, two natural incretin hormones. Cyanocobalamin will help increase energy.

GIP has decreased food intake and increased energy expenditure, resulting in weight reductions. Combined with a GLP-1 receptor agonist, it has a more significant effect on glucose and body weight effects.​​​​​​​

  • Substantial A1C reductions

  • Boosted weight loss

  • Improvements in cardiometabolic measures

  • Reduce appetite

  • ​​​​​​​Reduce Constipation

  • Less side effects than Semaglutide

  • Less adverse effects on gastric indigestion

Providing weight loss results comparable to bariatric surgery

According to studies, one-third of those on Mounjaro lose 25% of their body weight.

Any medical weight loss program you use can be combined with others.
ReAlignMed ReAlignMed 773-665-4400 773-665-4400